8-1929314-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014629.4(ARHGEF10):​c.2950T>G​(p.Ser984Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0634 in 1,613,890 control chromosomes in the GnomAD database, including 3,648 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S984S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.050 ( 265 hom., cov: 33)
Exomes 𝑓: 0.065 ( 3383 hom. )

Consequence

ARHGEF10
NM_014629.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.48

Publications

25 publications found
Variant links:
Genes affected
ARHGEF10 (HGNC:14103): (Rho guanine nucleotide exchange factor 10) This gene encodes a Rho guanine nucleotide exchange factor (GEF). Rho GEFs regulate the activity of small Rho GTPases by stimulating the exchange of guanine diphosphate (GDP) for guanine triphosphate (GTP) and may play a role in neural morphogenesis. Mutations in this gene are associated with slowed nerve conduction velocity (SNCV). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
ARHGEF10 Gene-Disease associations (from GenCC):
  • autosomal dominant slowed nerve conduction velocity
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • hereditary peripheral neuropathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • peripheral neuropathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015234053).
BP6
Variant 8-1929314-T-G is Benign according to our data. Variant chr8-1929314-T-G is described in ClinVar as Benign. ClinVar VariationId is 1229340.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0704 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGEF10NM_014629.4 linkc.2950T>G p.Ser984Ala missense_variant Exon 25 of 29 ENST00000349830.8 NP_055444.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGEF10ENST00000349830.8 linkc.2950T>G p.Ser984Ala missense_variant Exon 25 of 29 1 NM_014629.4 ENSP00000340297.3
KBTBD11-OT1ENST00000635855.1 linkn.*2904T>G non_coding_transcript_exon_variant Exon 26 of 30 5 ENSP00000489726.1
KBTBD11-OT1ENST00000635855.1 linkn.*2904T>G 3_prime_UTR_variant Exon 26 of 30 5 ENSP00000489726.1

Frequencies

GnomAD3 genomes
AF:
0.0504
AC:
7674
AN:
152202
Hom.:
265
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0132
Gnomad AMI
AF:
0.0526
Gnomad AMR
AF:
0.0443
Gnomad ASJ
AF:
0.0827
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0412
Gnomad FIN
AF:
0.0812
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0720
Gnomad OTH
AF:
0.0554
GnomAD2 exomes
AF:
0.0545
AC:
13694
AN:
251466
AF XY:
0.0560
show subpopulations
Gnomad AFR exome
AF:
0.0123
Gnomad AMR exome
AF:
0.0283
Gnomad ASJ exome
AF:
0.0839
Gnomad EAS exome
AF:
0.000544
Gnomad FIN exome
AF:
0.0789
Gnomad NFE exome
AF:
0.0722
Gnomad OTH exome
AF:
0.0613
GnomAD4 exome
AF:
0.0647
AC:
94603
AN:
1461570
Hom.:
3383
Cov.:
32
AF XY:
0.0648
AC XY:
47116
AN XY:
727112
show subpopulations
African (AFR)
AF:
0.0124
AC:
416
AN:
33474
American (AMR)
AF:
0.0301
AC:
1344
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0841
AC:
2198
AN:
26136
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39700
South Asian (SAS)
AF:
0.0433
AC:
3736
AN:
86242
European-Finnish (FIN)
AF:
0.0781
AC:
4170
AN:
53420
Middle Eastern (MID)
AF:
0.0945
AC:
537
AN:
5680
European-Non Finnish (NFE)
AF:
0.0707
AC:
78660
AN:
1111814
Other (OTH)
AF:
0.0584
AC:
3526
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
4612
9224
13835
18447
23059
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2752
5504
8256
11008
13760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0504
AC:
7676
AN:
152320
Hom.:
265
Cov.:
33
AF XY:
0.0505
AC XY:
3762
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0132
AC:
547
AN:
41576
American (AMR)
AF:
0.0443
AC:
678
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0827
AC:
287
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5180
South Asian (SAS)
AF:
0.0414
AC:
200
AN:
4830
European-Finnish (FIN)
AF:
0.0812
AC:
861
AN:
10608
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0721
AC:
4902
AN:
68024
Other (OTH)
AF:
0.0548
AC:
116
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
388
775
1163
1550
1938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0636
Hom.:
974
Bravo
AF:
0.0448
TwinsUK
AF:
0.0707
AC:
262
ALSPAC
AF:
0.0675
AC:
260
ESP6500AA
AF:
0.0150
AC:
66
ESP6500EA
AF:
0.0710
AC:
611
ExAC
AF:
0.0546
AC:
6629
Asia WGS
AF:
0.0230
AC:
79
AN:
3478
EpiCase
AF:
0.0714
EpiControl
AF:
0.0704

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

ARHGEF10-related disorder Benign:1
May 30, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
17
DANN
Benign
0.29
DEOGEN2
Benign
0.0
.;.;.;T;.
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.35
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.0
.;.;.;.;.
MetaRNN
Benign
0.0015
T;T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.0
.;.;.;L;.
PhyloP100
3.5
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.95
N;N;N;N;N
REVEL
Benign
0.059
Sift
Benign
0.64
T;T;T;T;T
Sift4G
Benign
0.58
T;T;T;T;T
Vest4
0.13
ClinPred
0.0079
T
GERP RS
2.7
Varity_R
0.044
gMVP
0.13
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17683288; hg19: chr8-1877480; COSMIC: COSV50664117; COSMIC: COSV50664117; API